发明名称 RECOMBINANT FACTOR VIII FORMULATIONS
摘要 Provided are liquid and lyophilized recombinant Factor VIII formulations, including formulations for polymer-conjugated FVIII such as PEGylated Factor VIII.
申请公布号 US2016030524(A1) 申请公布日期 2016.02.04
申请号 US201414774191 申请日期 2014.03.11
申请人 BAYER HEALTHCARE LLC 发明人 WANG De Qian;MA Xinghang;TSVETKOVA Nelly
分类号 A61K38/37;A61K47/02;A61K47/22;A61K47/48 主分类号 A61K38/37
代理机构 代理人
主权项 1. A rFVIII formulation comprising: (a) a range of from about 1 mM to about 5 mM divalent cation; (b) a range of from about 150 mM to about 250 mM sodium chloride or potassium chloride; (c) a range of from about 50 ppm to about 200 ppm of a non-ionic surfactant; and (d) a range of from about 100 IU/ml to about 5000 IU/ml of a rFVIII, wherein the rFVIII comprises an amino acid sequence that has one or more non-cysteine residues in the amino acid sequence of SEQ ID NO: 3 replaced with cysteine residues such that at least one pair of cysteine residues creates a disulfide bond not found in wild type FVIII;  wherein the rFVIII formulation has a pH in a range of from about pH 6.0 to about pH 7.5.
地址 Whippany NJ US